2026 NPPES data Hematology & Oncology Physician NPI 1508938192 M.D.
Verify on CMS →

JOSEPH GALL, M.D.

Hematology & Oncology Physician in GREENSBURG, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
7K
Medicare Part D claims · 266 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

JOSEPH GALL, M.D. filed 7,401 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in GREENSBURG, Pennsylvania, prescribing 87% generic.

7K
Part D claims, 2023
87%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOSEPH GALL, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

7,401 Top 3% higher than 97% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

JOSEPH GALL, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JOSEPH GALL, M.D.?

Quality data not reported

NPI registry status

Active

Issued 11/15/2006

NPI 1508938192

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

7,401 774% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Pennsylvania

How Hematology & Oncology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Hematology & Oncology Physician share within Pennsylvania

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOSEPH GALL, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 562 SHEARER ST, GREENSBURG, PA, 15601, with a listed phone of (724) 832-3960. NPI 1508938192 was issued on 11/15/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GALL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 7,401 prescription claims written by this provider, covering 266 Medicare beneficiaries and totaling roughly $487K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 1.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

562 SHEARER ST
GREENSBURG, PA 15601

Provider Details

NPI 1508938192
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 11/15/2006

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to JOSEPH GALL, M.D.. To verify JOSEPH GALL, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

JOSEPH GALL, M.D. — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 7,401 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

7,401
Total Claims
$487K
Total Drug Cost
266
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,233
Total Day Supply
181,546
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$374K
Generic Drug Cost
$112K
Opioid Claims
136 (1.8% rate)
Antibiotic Claims
120

Patient Demographics

Average Patient Age
84.2 years
Avg HCC Risk Score
1.89
Gender Split
75% female / 25% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JOSEPH GALL, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
521
Furosemide
351
Sertraline Hcl
331
Levothyroxine Sodium
323
Pantoprazole Sodium
229
Eliquis
Apixaban
221
Metoprolol Tartrate
209
Potassium Chloride
206
Omeprazole
188
Lisinopril
179

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How JOSEPH GALL, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

JOSEPH GALL, M.D.'s 7,401 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as GALL.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOSEPH GALL, M.D.'s specialty?
JOSEPH GALL, M.D. specializes in Hematology & Oncology Physician and practices in GREENSBURG, Pennsylvania. Credentials: M.D..
How much does JOSEPH GALL, M.D. prescribe under Medicare Part D?
In 2023, JOSEPH GALL, M.D. wrote 7,401 Medicare Part D claims totaling $487K in drug costs for 266 beneficiaries.
Where is JOSEPH GALL, M.D. located?
JOSEPH GALL, M.D. is located at 562 SHEARER ST, GREENSBURG, PA, 15601. Phone: (724) 832-3960.
What is JOSEPH GALL, M.D.'s NPI number?
JOSEPH GALL, M.D.'s National Provider Identifier (NPI) is 1508938192, issued on 11/15/2006.
Does JOSEPH GALL, M.D. prescribe more brand-name or generic drugs?
JOSEPH GALL, M.D.'s prescribing is 13% brand-name and 87% generic drugs by claim count, with $374K in brand drug costs.
Does JOSEPH GALL, M.D. prescribe opioids?
Yes, JOSEPH GALL, M.D. had 136 opioid claims in 2023 with an opioid prescribing rate of 1.8%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does JOSEPH GALL, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JOSEPH GALL, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Furosemide, Sertraline Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOSEPH GALL, M.D. accept Medicare?
JOSEPH GALL, M.D. appears in CMS Medicare data with 7,401 Part D claims and 266 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOSEPH GALL, M.D.'s credentials?
JOSEPH GALL, M.D.'s NPI is 1508938192 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology